ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2026; 51(2): 369-373


Risk of Herpes Zoster infection in patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRDs) and its relation to different DMARDs

Saad Saleem, Taqdees Khaliq, Sarah Azam Shah, Sumyra Saleem, Benish Adil.



Abstract
Download PDF Post

Objective: To determine the frequency of herpes zoster (HZ) in patients with diverse autoimmune rheumatic conditions taking different disease-modifying drugs (DMARDs) and immunosuppressants.
Methodology: This cross-sectional descriptive study was carried out in the Rheumatology and Dermatology Units of Federal Government Polyclinic Hospital, Islamabad from 12th March to 12th Sept 2022. A total of 243 patients, including both males and females with established diagnoses of different AIIRD were enrolled through a consecutive non-probability sampling technique. Data were analyzed using SPSS 23.
Results: Out of 243 patients, 59 (24.3%) were male and 184 (75.7%) were female with a mean age of 40.9±13.4 years. The minimum age of the patients was over 1 year. Among AIIRD, rheumatoid arthritis was the most common disease (59.3%), followed by systemic lupus erythematosus (12.3%). Herpes zoster (HZ) infection developed in 17 out of 243 patients, showing a prevalence of 6.9% in AIIRD. A substantial number of HZ infections (55.6%) were attributable to SLE. Out of 17 patients, 47% were on a prescribed combination therapy of corticosteroids and immunosuppressants (p

Key words: Autoimmune inflammatory rheumatic diseases (AIIRD), Systemic Lupus Erythematosus (SLE), Herpes Zoster (HZ).





Bibliomed Article Statistics

3
R
E
A
D
S

1
D
O
W
N
L
O
A
D
S
05
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.